# A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.

> **NCT04866225** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Oral [14C]PF-06865571
- **DRUG:** Oral PF-06865571
- **DRUG:** IV [14C]PF-06865571

## Key facts

- **NCT ID:** NCT04866225
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-11
- **Primary completion:** 2021-07-11
- **Final completion:** 2021-08-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866225, "A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04866225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*